129667864386084142_18624th release announcement, and silver Kai Shen Hua group holding limited, XI ' an medical management company has signed the share transfer contract, intended to $ 297 million from China and silver Kai Shen medical the Xian high-tech holds hospital Ltd, 92.94% shares. The equity trading at Xian high-tech hospital limited accountsNet premium rate was 39.01%, after the deal was completed, it will become the company's wholly-owned subsidiary. This asset injection good quality, acquisition of PE only 16.5 times times. Xian high-tech hospital, Ltd is China's first private tertiary hospital, cumulative reception more than 2.6 million passengers since 2006, bed occupancy rate of more than 85%, in Xian
diablo 3 gold, Shaanxi ProvinceAnd the country has a certain popularity. The 2009, 2010, 2011, by the end of October the total assets of $ 809 million, $ 612 million, respectively, $ 552 million
Diablo 3 Power Leveling, net profit respectively,-$ 4.0817 million to $ 14.8691 million, HK $, removal of sporadic 2010 reduction of disposal of assetsValue losses, reported net income of 8.5144 million dollars, with strong sustained profitability. We assume that Xian high-tech hospital 2010-year net profit of $ 18 million, corresponding to the current price PE only 16.5 times times, new century investment at present PE was 25 times times, price attractive. Inject assets have increased performance space, profitability uncertain. AsHas the right to autonomous pricing charges for medical services of for-profit hospitals, compared with the equivalent standards of hospital, Xian high per capita costs of hospital outpatient and in-patient costs per capita lower future growth space. In addition, commitments under this agreement, from 2012 to 2014, Xian high-tech hospital, Ltd net profit after deduction of nonrecurring, respectively, not lowAt 2,083. $ 790,000, 3,167.40,000 yuan, 4,217. $ 850,000, if less than the above net profit, Shen China and silver Kai medical disposable would make up the difference in cash, thus ensuring inject assets profitability. Company's strategic positioning in the retail and equity investment wing development, this project will provide equity investment companies provide new benefitsRun growth points, so as to enhance the company's overall performance level. We assume that the injected Xian high-tech hospital 2012 year net profit of $ 25 million, which increased earnings per share of $ 0.04, today a share than hospital valuations between 40-50 between times of such companies, we keep giving it 30 times times more dynamic valuations, contribution to value of $ 1.2 per share; 2012 years commercial core business EPS on the contribution of approximately $ 0.26, for 22 times times dynamic valuations, contribution to value of $ 5.72 per share, which our company the 2012 target price from $ 6.92 per cent, maintaining the "recommended" rating. (Specific content please see annex)
No comments:
Post a Comment